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ABSTRACT 
Objective: The present study is focused on the synthesis of novel Mannich bases and their metal complexes, and to characterize them by physical, 
chemical and biological methods. Mannich bases, 2-(piperazin-1-yl(thiophen-2-yl)methyl)hydrazinecarboxamide (PTMHC), 2-(piperazin-1-
yl(thiophen-2-yl)methyl)hydrazinecarbothioamide (PTMHCT), and 2-((4-methylpiperazin-1-yl)(thiophen-2-yl)methyl)hydrazinecarboxamide 
(MPTMHC) and 2-((4-methylpiperazin-1-yl)(thiophen-2-yl)methyl)hydrazinecarbothioamide (MPTMHCT), were prepared by Mannich 
condensation method.  
Methods: The compounds and complexes were prepared by known literature methods. Characterizations were carried out through physical 
methods such as elemental analyses, melting point and TLC. IR, 1H NMR, 13C NMR and Mass spectral studies were carried out to characterize the 
ligands. The methods like EPR, magnetic susceptibility measurements, conductance measurements and thermal analysis were carried out for 
complexes besides the UV-Vis and IR spectral studies. Anti-cancer activity of synthesized ligands was performed using human lung and colon cancer 
cell lines. 
Results: Eight compounds have been prepared and characterized. Four among the eight compounds were used as ligands for the preparation of 
metal complexes. The results of physical and chemical methods show all the complexes act as bidentate ligands. The coordination with the metal ion 
takes place through N, S and O atoms. The results of molar conductivity and magnetic susceptibility measurements reveal the electrolytic and non-
electrolytic nature of the metal complexes. EPR and TG-DTA studies also support the other spectral data.  
Conclusions: Copper (II) complexes of PTMHC, PTMHCT, MPTMHC, and MPTMHCT were prepared and their structures were determined. The anti-
cancer activity of the synthesized ligands and their complexes was evaluated. The synthesized novel ligands of Mannich bases can serve as a 
potential anti-cancer agent.  
Keywords: Mannich base metal complexes, Thiophene-2-carbaldehyde, Anticancer activity of metal complexes and ESR. 
 
INTRODUCTION 
Cancer is one of the most vulnerable diseases characterized by the 
uncontrolled, rapid and pathological proliferation of abnormal cells 
which ultimately leads to tissue invasiveness and is one of the most 
terrible afflictions in the world [1]. In recent years, many efforts 
have been taken by researchers to eradicate this disease, as a result 
of improvements in cellular and molecular biology leading to the 
development of potent anticancer agents that are capable of 
targeting the cancerous tissues with nominal side effects [2]. Even 
though these advancements along with the design of cancer 
chemotherapy have increased our understanding of cancer 
inheritance, it still remains as a complex disease and a cure for 
cancer is quite challenging to the scientific community [3]. 
Metal-based compounds attracted medicinal chemists very much 
because of their wide range of coordination numbers and 
geometries, accessible oxidation-reduction states, thermodynamic 
and kinetic characteristics, and the intrinsic properties of the 
cationic metal ion and ligand. Metal-based compounds were 
employed as anti-cancer agents after the discovery of the biological 
activity of cisplatin. Extensive studies have been made on the 
synthesis and characterization of metal complexes of Mannich bases 
in recent years due to its selectivity and sensitivity of ligands 
towards various metal ions [4–9]. Metal complexes of O, N donor 
ligands are found to possess interesting biological activities such as 
anti-cancer, anti-tubercular and anti-microbial. Metal-based 
compounds offer possibilities for the design of therapeutic agents 
that are not readily available to organic compounds. A commendable 
number of reports are available in the literature on the synthesis of 
Mannich bases using formaldehyde, amines (10/ 20) and substrates 
like phenol, heterocyclic compounds, alkyl ketones, alkynes and 
carboxylic acid derivatives. In the recent years, much work have 
been carried out using acyclic carboxamide as substrate for the 
synthesis of Mannich bases.[ 446,447] Raman et al., have reported 
the synthesis and characterization of transition metal (II) complexes 
of a Mannich base which was prepared by reacting benzaldehyde, 
morpholine and semicarbazide. Abdul Jameel et al., reported 
synthesis, characterization and anti-microbial studies of Mannich 
bases using semicarbazide as a substrate. Further, they reported the 
synthesis and characterization of metal complexes of the same [10-
14]. From the literature, it has been revealed that Mannich bases 
derived from semicarbazide / thiosemicarbazide and their metal 
complexes possess potent anti-microbial activity against the 
selected microorganism. A probe into the literature clearly indicates 
that the Mannich bases of heterocyclic molecules and their metal 
complexes are found to posse’s anti-cancer activity besides other 
biological activities. In view of the biological significance of Mannich 
bases, an effort has been made to synthesize Mannich bases using 
semi / thiosemicarbazide as a substrate by reacting with thiophene 
2-carbaldehyte and N – Methyl piperazine / piperazine according to 
the prescribed schemes. In the present study, the compounds thus 
obtained by the above reactions were used as ligands for the 
preparation of Cu(II) complexes.  
The structures of both the compounds and complexes were 
characterized by analytical and spectral methods. Further, they were 
screened for anti-cancer activity against human lung cancer (A 549), 
Colon cancer (HCT 15) and normal (VERO) cells.  
MATERIALS AND METHODS 
Reactants  
Analytical grade solvents and reactants were used. 
Thiosemicarbazide, N- Methyl piperazine, piperazine and thiophene-
2-carbaldehyde were purchased from Merck Products.  
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Elemental analyses and characterization studies were carried out at 
Sophisticated Analytical Instrument Facility (SAIF), Indian Institute 
of Technology, Government of India, Chennai. Melting points were 
measured on electric melting point apparatus SMP1. 1H NMR spectra 
were recorded on 300 MHz Shimadzu spectrometer using DMSO-d6 
with TMS as the internal standard. The homogeneity of the 
compounds was monitored by Thin Layer Chromatography (TLC) 
Silica-G coated glass plate and visualized by iodine vapour. The 
absorption in the UV-Vis region was recorded for the compounds by 
a Perkin Elmer Lambda 35 spectrophotometer using DMF/DMSO as 
solvents. The IR spectra was recorded with a Bruker FTIR Vector 22 
spectrometer between 4400 and 400 cm-1 (KBr disks).  
The molar conductance of solid complexes in DMF was measured 
using conductometer. The magnetic susceptibilities of the solid 
complexes were recorded on Magnetic Susceptibility Balance. 
Thermogravimetric analyses were carried out in a nitrogen 
atmosphere with a heating rate of 25oC min-1 using a Shimadzu TGA-
50H.Electrochemical measurements were carried out using 
electrochemical Analyzer model BAS-50 voltammograph. The three-
electrode cell contained a reference Ag/ AgCl electrode, Pt wire 
auxiliary electrode and glassy carbon working electrode. ESR 
spectra of the copper complex were recorded on a Varian E112 X- 
band spectrometer at the Regional Sophisticated Instrumentation 
Centre, Indian Institute of Technology, Chennai using 
tetracyanoethylene (TCNE) as the internal standard. Anti-cancer and 
cytotoxic studies were carried out at Royal Bio Research Centre, 
Chennai. 
 
Scheme 1: Synthesis of compounds (A and B) 
 
 
Scheme 2: Synthesis of compounds (B and C) 
 
Experimental  
Synthesis of mannich base 
2-((4-methylpiperazin-1-yl)(thiophen-2-
yl)methyl)hydrazinecarboxamide (MPTMHC) was prepared by 
reacting semicarbazide hydrochloride (0.05 mol), N- Methyl 
piperazine (0.05 mol) and thiophene-2-carbaldehyde (0.05 mol) in 
1:1:1 mol ratio. To the methanolic solution of semicarbazide 
hydrochloride, N- Methyl piperazine was added slowly followed by 
liq. NH3. This reaction mixture was stirred well using magnetic 
stirrer. After a few minutes, thiophene-2- carbaldehyde was added 
drop by drop to the reaction mixture. Then the reaction mixture was 
allowed to stand at 5oC for 5 h. The colorless solid thus obtained was 
washed with water several times and finally with the 1:1 mixture (V 
/ V) of acetone and petroleum ether. Later, it was filtered and dried 
in vacuum. The same procedure was employed for the synthesis of 
the rest of the compounds. [10-17]. 
Preparation of complexes 
To a methanolic solution of ligand (L1-L4) (Scheme and Fig. 1 – 2), 
Cu(II) chloride was dissolved in mixture of CHCl3 and CH3OH (1:2) V 
/V was added. The resulting mixture was stirred well by keeping on 
a magnetic stirrer for 2 h, during which solid separated out was 
collected by filtration, washed with methanol followed by diethyl 
ether and dried in vacuum. (Fig. 3, 4, 5 and 6) 
 
 
Fig. 1: Cytotoxic study of normal cell line (VERO) and cancer cell 
line (A549) of compound (a) and (c). 
 
 
Fig. 2: Anticancer activity of normal cell line (VERO) and cancer 
cell line (HCT15) of compound (a) and (c). 
 
Anticancer (cytotoxic) evaluation 
The anticancer activity of the synthesized ligands MPTMHCT, 
MPTMHC and their metal complexes were determined against 
human lung cancer (A549) cell and colon cancer (HCT15) cell lines. 
The cancer cell lines were obtained from the National Centre for cell 
sciences (NCCS), Pune. The cell line was cultured in minimum 
essential media fetal bovine serum supplemented with 10 % heat 
inactivated fetal bovine serum (FBS), penicillin (100 µg/mL) and 
streptomycin (100 µg/mL) in a humidified atmosphere of 50 µg/mL 
CO2 at 37 oC. The experiment was carried out at Royal Bio Research 
Centre. Anticancer activity of synthesized ligands at various 
concentrations was assessed using the trypsin, methylthiazol, 
diphenyl- tetrazolium bromide (MTT) (Sigma) assay, as described by 
Mosmann, but with minor modification, following 72 h of incubation. 
Assay plates were assessed using spectrophotometer at 520 nm. 
Data generated were used to plot a dose–response curve, from 
which the concentration of test compounds required to kill 50% of 
the cell population (IC50) were determined.[18-22] The effect of the 
samples on the proliferation of A549, HCT15 & VERO cells was 
expressed as the % cell viability, using the following formula: 
 
Padusha et al. 




Fig. 3:    [Bis (2-((4-methylpiperazin-1-yl)(thiophene-2-yl) methyl) 
hydrazine carbothioamide) dichloro copper (II) .] 
 
Fig. 4:   [Bis (2-((piperazin-1-yl)(thiophene-2-
yl)methyl)hydrazinecarbothioamide) dichloro copper (II) .] 
 
Fig. 5: [Diaqua Bis(2-((4-methylpiperazin-1-yl)(thiophene-2-
yl)methyl)hydrazinecarboxamide) copper (II) .]  
 
Fig. 6: [Diaqua Bis(2-((piperazin-1-yl)(thiophene-2-yl)methyl) 




RESULTS AND DISCUSSION 
Characterization 
Physicochemical characterization of the synthesized compounds 
was done by the analytical methods such as melting point, TLC, 
elemental analysis, and spectral methods such as UV – Visible, IR, 1H 
NMR, [13]C NMR and Mass. For the complexes molar conductivity, 
elemental analysis and magnetic susceptibility studies were also 
carried out besides UV-Vis, IR, ESR, Mass Spectra and TG-DTA 
studies to determine the structures.  
1H NMR spectra 
Unfortunately, the insolubility of Cu(II) complexes in CDCl3, CD3COCD3 or 
DMSO-d6 makes it difficult to carry out 1H NMR spectra of the complexes 
to further clarify the way of binding of HL ligand to the metal ions. 
2-((4-methylpiperazin-1-yl)(thiophen-2-
yl)methyl)hydrazinecarbothioamide (MPTMHCT) (L) (Fig. 1) A 
IR (KBr, cm-1) 3411(NaH2), 3150 (NcH), 1595(NbH), 1084(-C=S), 
1142(C-N-C). 1H NMR (300 MHz, DMSO-d6, δ ppm) 7.53 (d, H, 
NH(C=S)), 7.47 (q, H,NH(CH)), 7.15 (m, 3H, thiophene), 4.17 (s, 1H, 
CH), 2.52 (m, 8H, piperazine), 2.23(s, 1H, N-CH3), 2.00(s, 1H, NH2). 
[13]C NMR (300 MHz, DMSO-d6, δ ppm) 170.14(-C=S, 
thiosemicarbazide), 150.07 (C-S, thiophene), 139.23-114.24 (Ar-CH), 
40.49(CH(NH)), 40.32-34.19 (Aliphatic - CH), 40.15 (N-H). The mass 
spectrum of the compound (L) exhibits a molecular ion peak[M] at 
m/Z 285 which is equivalent to its molecular weight. The 
fragmentation peaks at m/z 252, 235, 219, 185, 99, 83, 73 indicate 
the cleavage of C11H21N5S, C11H20N4S, C11H19N3S, C6H9N3S2, C5H12N2, 
C4H4S and CH4N2S fragments respectively. Base peak appears at m/z 
109. 
2-(piperazin-1-yl(thiophen-2-
yl)methyl)hydrazinecarbothioamide (PTMHCT)(L)(Fig. 2) B 
IR (KBr, cm-1) 3424(NaH2), 3355(NcH), 1606(NbH), 1077(-C=S), 
1156(C-N-C). 1H NMR (300 MHz, DMSO-d6, δ ppm) 7.6 (d, H, 
NH(C=S)), 7.53-7.52 (q, H,NH(CH)), 7.25-7.23 (m, 3H, thiophene), 
4.31 (s, 1H, CH), 2.50 (m, 8H, piperazine), 2.0(s, 1H, N-H), 1.90(s, 1H, 
NH2). [13]C NMR (300 MHz, DMSO-d6, δ ppm) 169.82(-C=S, 
thiosemicarbazide), 150.17 (C-S, thiophene), 137.32-114.04 (Ar-CH), 
40.48(CH(NH)), 40.31-34.54 (Aliphatic - CH), 40.14 (N-H). The mass 
spectrum of the compound (L) exhibits a molecular ion peak[M] at 
m/Z 271 which is equivalent to its molecular weight. The 
fragmentation peaks at m/z 243, 202, 184, 96, 90, 85 indicate the 
cleavage of C10H19N5S, C7H17N5S, C9H14N2S, C5H6S, CH5N3S, and 
C4H10N2 fragments respectively. Base peak exhibits at m/z 110. 
2-((4-methylpiperazin-1-yl)(thiophen-2-
yl)methyl)hydrazinecarboxamide (MPTMHC) (L) (Fig. 3) C 
IR (KBr, cm-1) 3655(OH), 3156(NaH2), 2924(NbH), 1600(-
C=N),1249(C-O),1179(C-N-C). 1H NMR (300 MHz, DMSO-d6, δ 
ppm) 7.88 (s, 2H, NH2), 7.45-7.44 (m, 3H,thiophene), 7.13-7.11 (d, H, 
NH(C=O)), 4.15 (s, H, CH(NH), 3.90 (s, 3H, CH3 (piperazine)), 2.51-
2.50 (m, 8H, piperazine), 1.92(s, H, NH(CH)). [13]C NMR (300 MHz, 
DMSO-d6, δ ppm) 150(N=C-OH, semicarbazide), 132.26 (C-S, 
thiophene), 121.89-114.97 (Ar-CH), 56.15(CH(NH)), 40.49-
21.50(Aliphatic - CH), 40.49 (N-CH3). The mass spectrum of the 
compound (L) exhibits a molecular ion peak[M] at m/Z 269 which is 
equivalent to its molecular weight. The fragmentation peaks at m/z 
234, 202, 186, 148, 114, 90, 82 indicate the cleavage of C10H18N4S, 
C9H16N3S, C7H17N5O, C6H16N4, C6H14N2, C5H3S and C4H4S fragments 
respectively. Base peak occurs at m/z 90. 
2-(piperazin-1-yl(thiophen-2-yl)methyl)hydrazinecarboxamide 
(PTMHC) (L) (Fig. 4) D 
IR (KBr, cm-1) 3800(OH), 3245(NaH2), 3153(NbH), 1599(-
C=N),1206(C-O),1156(C-N-C). 1H NMR (300 MHz, DMSO-d6, δ 
ppm) 9.95(s, 1H, N=C-OH), 7.85(s, 2H, NH2), 7.13(m, 3H, 
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Thiophene), 4.18(s, 1H,CH), 2.56 (m, 8H, piperazine), 2.40 (d, 1H, N-
H(CH)), 1.92(s,1H, NH of piperazine). [13]C NMR (300 MHz, DMSO-
d6, δ ppm) 150.02(N=C-OH, semicarbazide), 139.75 (C-S, 
thiophene), 130.75-121.89 (Ar-CH), 56.15(CH(NH)), 40.50-
21.50(Aliphatic - CH), 40.50 (N-H). The mass spectrum of the 
compound (L) exhibits a molecular ion peak [M] at m/Z 271 which is 
equivalent to its molecular weight. The fragmentation peaks at m/z 
218, 194, 184, 177, 168, 131, 114, 84 indicate the cleavage of 
C9H16N4S, C9H15N3S, C9H14N2S, C7H16N4O, C6H9N3OS, C5H14N4, C5H13N3 
and C4H10N2 fragments respectively. Base peak lies at m/z 110. 
Bis [2-((4-methylpiperazin-1-yl)(thiophene-2-yl)methyl) hydra-
zinecarbothioamide copper (II) chloride] (Fig. 5) 
IR (KBr, cm-1) 3400(NaH2), 3134 (NcH), 1610(NbH), 1068(-C=S), 
1142(C-N-C). 1H NMR (300 MHz, DMSO-d6, δ ppm) 7.53 (d, H, 
NH(C=S)), 7.47 (q, H,NH(CH)), 7.15 (m, 3H, thiophene), 4.17 (s, 1H, 
CH), 2.52 (m, 8H, piperazine), 2.23(s, 1H, N-CH3), 2.00(s, 1H, NH2). 
[13]C NMR (300 MHz, DMSO-d6, δ ppm) 170.14(-C=S, 
thiosemicarbazide), 150.07 (C-S, thiophene), 139.23-114.24 (Ar-CH), 
40.49(CH(NH)), 40.32-34.19 (Aliphatic - CH), 40.15 (N-H). The mass 
spectrum of the compound [CuL2Cl2] exhibits a molecular ion peak 










The ESR spectra of the complexes was recorded in the solid state at 
room temperature. The giso, gII and g┴  values are presented in table 
1. From the observed g values, it is clear that the unpaired electron 
lies predominantly in the dx2-y2. According to the studies of Nieman, 
the gII value complexes greater than 2.3 are usually ionic in nature 
and less than 2.3 are covalent in nature. In the present study, the g 
values of all the complexes are found to be less than 2.3 indicating 
the covalent nature of the complexes. 
Thermal Analysis 
The nature of thermal stability and the molecules that are desorbed 
or buried in the complexes with respect to temperature was studied 
by TGA and compared with the literature and are presented in (Fig. 
5). The complex [CuL2Cl2] was heated in the nitrogen atmosphere 
with a heating rate of 25oC min-1. The following thermogram shows 
three stages. The first mass change 9.30 % at 57-146.6oC indicates 
the loss of moisture. The second stage between 146.6 - 413.3oC with 
the mass change of 34.63 corresponds to the loss of ligand chloride. 
Further, decomposition of other ligand moieties takes place at 
413.3oC and remains stable upto1400 oC. 
  
Table 1: Solid State EPR spectral parameters of the Cu(II) complexes of Ligands (PTMHC, PTMHCT, MPTMHC, and MPTMHCT) 
S. No. Compound/Complex gII g┴  gaverage/ giso 
1. C22H36Cl2CuN10S4 2.18 2.04 2.13 
2. C20H32Cl2CuN10S4 2.20 2.10 2.16 
3. C22H40CuN10O4S2 2.09 2.13 2.10 
4. C20H36CuN10 O4S2 2.21 2.09 2.17 
 
The complex [CuL2(OH)2] (Fig. 5) was heated in nitrogen 
atmosphere with a heating rate of 25oC min-1. The thermogram 
shows three different regions. The first weight loss 29.78 % at 180-
300oC indicates the loss of two water molecules. This is further 
supported by the color change due to the change of co-ordinated 
from 6 to 4. The region between 180 - 350oC and 780-1063oC 
corresponds to the loss of coordinated organic moieties. The third 
region starts at 1060oC and stays stable up to 1400oC and the weight 
loss found to be about 72.77% for this step. The residue of metal 
atom remains behind because under nitrogen atmosphere no metal 
oxide will be formed. 
Metal complexes 
The physiochemical parameters are shown in Table 2 and Table 3. 
The elemental analyses show 1:2 (metal: ligand) stoichiometry for 
all complexes. The analytical data of the ligands and their complexes 
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are in good agreement with the proposed structures. The low molar 
conductance values of the complexes of [CuL2Cl2] (Fig. 3) and 
[CuL2Cl2] (Fig. 4) support the non-electrolytic nature and high 
conductance values of the complexes of [CuL2(OH)2] (Fig. 5) and 
[CuL2(OH)2] (Fig. 6) favour the electrolytic nature. 
 
 
TGA and DTA curve of [CuL2(OH)2] Complex 
 
IR spectra and mode of bonding 
The important characteristics stretching frequencies of the ligands 
and their complexes are compared and the values are tabulated in 
Table 4 and Table 5. From the table it has been clearly reveals that 
the MPTMHCT and PTMHCT behave as neutral bidentate ligands and 
MPTMHC and PTMHC behave as monobasic bidentate ligands. For 
the complexes [CuL2Cl2] (Fig. 3) and [CuL2Cl2] (Fig. 4), the IR 
absorption bands of ν(NcH) and ν(C=S) of the ligands have been shifted 




TGA and DTA curve of [CuL2Cl2] Complex 
 
These changes indicate the participation of sulphur atom of C=S and 
nitrogen atom of -NcH in coordination with the metal ion. There have 
been no changes observed in other characteristics absorption bands 
such as νC-N-C and νC-S-C. These rules out the involvement of nitrogen 
atom of piperazine ring and sulphur atom of thiophene ring. In the 
case of [CuL2(OH)2] (Fig. 5) and [CuL2(OH)2] (Fig. 6) complexes, the 
IR absorption bands due to ν(OH) of the free ligand is found absent in 
the complexes. ν(C=O) modes of the free ligands are not observed 
which indicate the enolisation of C=O followed by deprotonation and 
complexation with metal ions. The bands due to ν(NbH) and ν(C-O) are 
found shifted to lower frequencies by15 to 30 cm-1 in the spectra of 
the complexes and another band due to ν(C=N) is slightly shifted to 
higher frequency in the spectra of the complexes. These changes 
indicate the participation of oxygen atom of OH after deprotonation 
and nitrogen atom of NcH in coordination with the metal ion. This is 
further confirmed by the presence of new bands at 545, 548 cm-1 
and 454, 452, 458, 449 cm-1 which are assigned to ν (M-O) and ν (M-N) 
respectively [10-11]. The band at 345 cm-1 is assigned to (M-S) 
which confirms the coordination of sulphur with the metal ion. 
 
Table 2: Mass spectral data, Elemental (C, H, N, S, O) Analytical data and % yield of compounds. 
S. 
No. 





Elemental analysis, [Found % (Calcd. %)] 
C H N O S Cu Cl 
1. C11H19N5S2 285.3 195 98 45.89(46.29) 6.02(6.71) 23.67(24.54) --- 22.46(22.47) --- --- 
2. C10H17N5S2 271.4 190 95 42.87(44.0) 5.46(6.31) 23.98(25.80) --- 23.16(23.63) --- --- 
3. C11H19N5OS 269.2 185 92 41.09(49.05) 7.11(7.12) 26.0(27.23) 5.94(6.00) 11.90(12.23) --- --- 
4. C10H17N5OS 271 188 92 44.0(47.04) 6.31(6.71) 25.80(27.43) 5.56(6.00) 10.63(12.56) --- --- 
5. C22H36Cl2CuN10S4 701 298 92 29.78(37.57) 4.0(5.16) 17.15(19.92) --- 13.28(18.24) 8.0 20.0 
6. C20H32Cl2CuN10S4 673.0 284 83 30.78(35.57) 4.0(4.78) 16.19(20.74) --- 14.24(18.99) 8.0 10.0 
7. C22H40CuN10O4S2 635.2 265 82 33.78(41.53) 5.1(6.34) 17.00(22.01) 8.19(10.6) 9.24(10.08) 9.0 --- 
8. C20H36CuN10O4S2 607.1 265 77 32.53(39.49) 4.19(5.97) 15.22(23.03) 8.33(10.5) 8.18(10.54) 9.0 --- 
 
Table 3: Molar conductance and magnetic susceptibility data of the complexes 
S. No. Compound/Complex Colour ʎ(mho cm2 mol-1) µeff.(BM) 
1. C22H36Cl2CuN10S4 Green 16.0 1.54 
2. C20H32Cl2CuN10S4 Green 15.0 1.48 
3. C22H40CuN10O4S2 Green 20.0 1.68 
4. C20H36CuN10 O4S2 Green 18.0 1.65 
 
Table 4: IR Spectral data of Ligands (L) and their metal complexes ([CuL2Cl2] and [CuL2Cl2]) 
S. No. Compound ν(NaH2) ν(NbH) ν(NcH) ν(C=S) ν(M-N) ν(M-S) 
1. L1 (Fig. 1) 3411 1595 3150 1084 ---- ----- 
2. [CuL2Cl2] 3400 1610 3134 1068 454 345 
3. L2 (Fig. 2) 3424 1606 3355 1077 ----- ----- 
4. [CuL2Cl2] 3410 1616 3342 1058 452 345 
 
Table 5: IR Spectral bands of Ligands (L) and their metal complexes ([CuL2(OH)2] and [CuL2(OH)2]). 
S. No. Compound ν(OH) ν(NaH2) ν(Nb-H) ν(C=N) ν(C-O) ν(M-N) ν(M-O) 
1. L3 (Fig. 3) 3655 3156 2924 1600 1249 ---- ---- 
2. [CuL2(OH)2] 3301 3155 2908 1620 1232 458 545 
3. L4 (Fig. 4) 3800 3245 3153 1599 1206 ---- ---- 
4. [CuL2(OH)2] 3678 3240 3140 1608 1991 449 548 
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Table 6: UV Spectral data of metal complexes ([CuL2Cl2], [CuL2Cl2]) and ([CuL2(OH)2], [CuL2(OH)2]). 
S. No. Compound/Complex Observed nm (cm-1) Transitions 
1. [CuL2Cl2] 604.50 (16556) 2Eg → 2T2g 
2. [CuL2]Cl2] 373.94 (26742) 2T2g → 2Eg 
3. [CuL2(OH2)] 415, 447 (24096, 22324) 2B1g → 2A1g, 2B1g → 2Eg 
4. [CuL2(OH)2] 420, 425 (23809, 23504) 2B1g → 2A1g, 2B1g → 2Eg 
  
Table 7: Cytotoxic study of normal cell line (VERO) and Lung cancer cell line (A549) of compound (a) and (c). 
S. No. Concentration µg/ml VERO CELL LINE A549 -Compound (a) A549 -Compound (c) 
1 1000 55.5 12.8 12.3 
2 500 60.3 21.5 21.8 
3 250 67.1 27.8 27.2 
4 125 71.6 45.0 44.9 
5 62.5 78.2 49.5 49.1 
6 31.2 89.3 64.2 63.1 
7 15.6 93.5 83.1 82.2 
8 7.8 98.4 92.3 91.3 
9 Control 100 100.0 100.0 
 
Table 8: Anticancer activity of normal cell line (VERO) and Colon cancer cell line (HCT15) of compound (a) and (c). 
S. No. Concentration µg/ml VERO CELL LINE HCT15 -Compound (a) HCT15 -Compound (c) 
1 1000 55.5 12.5 11.0 
2 500 60.3 18.5 16.2 
3 250 67.1 25.6 24.3 
4 125 71.6 43.5 42.5 
5 62.5 78.2 48.1 47.0 
6 31.2 89.3 62.1 61.1 
7 15.6 93.5 80.5 78.2 
8 7.8 98.4 90.3 88.8 
9 Control 100 100.0 100.0 
 
UV-Vis spectroscopy 
Electronic spectra of complexes were recorded in DMSO solution. 
For[CuL2Cl2](Fig. 3) complex, an absorption band exhibited at 16656 
cm-1 is assigned to 2Eg →2T2g transition. This corresponds to 
octahedral geometry of the complex. The absorption band exhibited 
at 26742 cm-1 for [CuL2Cl2](Fig. 4) complex is assigned to 2T2g →2Eg 
transition, favouring octahedral geometry. [CuL2(OH)2] (Fig. 5) 
complex shows two absorption bands at 24096 cm-1and 22324 cm-1. 
These absorptions are assigned to 2B1g →2A1g and 2B1g →2Eg 
transitions respectively, suggesting octahedral geometry. In the case 
of [CuL2(OH)2] (Fig. 6) complex, two absorption bands are exhibited, 
one at 23809 cm-1 and another at 23504 cm-1 whichare assigned to 
2B1g →2A1g and 2B1g →2Eg respectively. These transitions favour 
octahedral geometry (Table 6). 
Anticancer activity 
The invitro anti-cancer activity of the synthesized compounds 
MPTMHCT, MPTMHC was studied against human lung cancer 
(A549), colon cancer (HCT15) and VERO cell lines. The results of the 
study are presented in Table 7 and 8 and their studies are shown in 
Fig. 1 and 2. In the present study, the normal cell line (VERO) shows 
55.5% of cell viability, 12.8 % of cell viability for human lung cancer 
cell A(549) and 12.5% of cell viability for colon cancer cell (HCT15) 
for the compound MPTMHCT at a concentration of 1000 µg/mL, 
55% of cell viability for VERO cell, 12.3% for A549 and 11.0% for 
HCT15 at a concentration of 1000 µg/mL were observed for the 
compound MPTMHC. 
CONCLUSION 
Mannich bases such as MPTMHCT, PTMHCT, MPTMHC and PTMHC 
were prepared. The results of physical and chemical methods reveal 
that the complexes act as bidentate ligands. From the IR and UV-
Visible studies, Octahedral geometries have been proposed for 
Cu(II) complexes of MPTMHCT, PTMHCT, MPTMHC and PTMHC. The 
coordination with the metal ion takes place through N, S and O 
atoms. The results of molar conductivity and magnetic susceptibility 
measurements reveal the electrolytic and non-electrolytic nature of 
the metal complexes. EPR and TG-DTA studies also support the other 
spectral data. Invitro anti-cancer study shows that both MPTMHCT and 
MPTMHC have moderate activity against the selected cell lines. 
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